cG250
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for cG250, covering 2021-05-14 to 2021-06-16. Get the full timeline:
Most recent: Clinical Trial Update: Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma [Phase 1]